With proper business development tools and insights into entrepreneurship, biomedical researchers can improve the potential of their discoveries in the laboratory reaching patients. I-Corps@NCATS, a University of Miami (UM) Clinical and Translational Science Institute (CTSI) program, helps entrepreneurial-minded researchers move their new drugs, diagnostics, technologies, and devices forward to the next stage of development.

The Research Advocacy and Quality Champions — a select group of UM’s very best Clinical Research Coordinators and Directors – meet once a month to advise the CTSI, Clinical Research Operations and Regulatory Support (CRORS), and the Human Subjects Research Office (HSRO) on system-level issues that can be improved to help study approval, start-up, and implementation activities go more smoothly.

Six Miami CTSI faculty have contributed articles to a newly released special issue of the Journal of Clinical and Translational Science on COVID-19. Explore the articles or read the entire online issue to discover the innovative ways the Clinical and Translational Science Awards (CTSA) program responded to the global health crisis.